# Medical Care Technologies

Medical Care Technologies is an Asset Manager.

## Overview

- **Organization type:** Asset Manager
- **Assets under management:** Undisclosed
- **Website:** medicalcaretechnologiesinc.com

## Regulatory record

- **Reports private funds:** No

## About

Medical Care Technologies Inc. incorporated in Nevada and established its operational base in Dongguan, Guangdong. The firm, led by CEO Ning Wu, positioned itself as a consolidator of community-based healthcare assets in China, beginning with its flagship Teddyberry Pediatric and Obstetric Medical Centers. The company pursued a strategy of acquiring and standardizing small private clinics that had historically operated with minimal branding, fragmented records, and little centralized purchasing power. The deployment thesis centered on direct acquisition of Chinese private healthcare clinics, with a stated mandate covering pediatric services, women's health, and general practice. The firm's initial asset was the Dongguan-based Teddyberry clinic network, which it intended to scale into a national chain. Geographically, operations were concentrated in Guangdong province, and the firm did not publicly disclose investments outside of mainland China. No institutional co-investors, fund commitments, or private-capital structures were ever documented; the firm operated exclusively as a publicly traded micro-cap entity. The firm never disclosed a meaningful professional headcount, total AUM, or deployment figure. As a publicly traded entity, it operated with minimal institutional backing and its team size was consistent with a small early-stage operating company. The firm had no known philanthropic foundations, real-asset arms, or club memberships. In October 2014, the Securities and Exchange Commission suspended trading in Medical Care Technologies' stock due to a lack of current and accurate information, effectively ending its viability as a public vehicle. The structural differentiator was entirely negative: Medical Care Technologies represents the classic regulatory-capture risk of a China-based operating company listed via a Nevada shell. While the roll-up thesis behind Teddyberry was coherent on paper, the firm lacked the reporting infrastructure, audited financials, and governance required for sustained public-market access, making it a permanent removal from any institutional allocation discussion.

## Questions

### Why did the SEC suspend trading in the firm's stock?

The Securities and Exchange Commission suspended trading in Medical Care Technologies Inc. on October 10, 2014, citing a lack of current and accurate information about the company. The suspension was executed under Section 12(k) of the Securities Exchange Act of 1934, effectively barring broker-dealers from soliciting investor interest in the stock until adequate disclosures were filed. The firm never resolved this deficiency.

### Does the firm maintain any known investment portfolio today?

No. There is no public record of Medical Care Technologies holding any active investment portfolio, conducting new acquisitions, or operating any healthcare facilities since the 2014 trading suspension. The entity remains inactive for all practical purposes related to institutional allocation.

### What is the known posture on co-investments alongside external GPs?

The firm never disclosed co-investment partnerships with external general partners or other institutional investors. Its acquisition strategy was direct and wholly-owned, without any documented LP or club-deal structures.

## Related profiles

- [One World Products, Inc.](https://altss.com/profile/one-world-products-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/medical-care-technologies-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology